We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
16 hedge funds and large institutions have $41M invested in ESSA Pharma in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
213% more capital invested
Capital invested by funds: $13.1M → $41M (+$27.9M)
100% more funds holding
Funds holding: 8 → 16 (+8)
3.38% less ownership
Funds ownership: 86.87% → 83.48% (-3.4%)
Holders
16
Holders Change
+8
Holders Change %
+100%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
5
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Blackstone Inc
New York
|
+$4.21M |
| 2 |
O
OrbiMed
New York
|
+$3.63M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$3.24M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.47M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.54M |
Top Sellers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$37 |
